Jeffrey S. Mathiesen - 02 Jun 2021 Form 4 Insider Report for NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)

Role
Director
Signature
/s/ Stephanie Swan, by Power of Attorney
Issuer symbol
NMTC
Transactions as of
02 Jun 2021
Transactions value $
$0
Form type
4
Filing time
04 Jun 2021, 16:29:18 UTC
Previous filing
27 May 2021
Next filing
15 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NMTC Common Stock Award $0 +4.59K +14.25% $0.00 36.8K 02 Jun 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NMTC Option to Purchase Common Stock Award $0 +4.68K $0.00 4.68K 02 Jun 2021 Common Stock 4.68K $7.26 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.
F2 The share amount has been adjusted to reflect the reverse stock split effective on March 31, 2021 whereby each three shares issued and outstanding prior to the split were combined and converted into one share of common stock.
F3 The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.